Evaluation reveals enhanced antitumor immunity against liver cancer, suggesting potential for advanced treatments.
The evaluation of PLT012's efficacy in inhibiting both primary and metastatic growth of MC38 colon cancer.
No takes yet. Share an insight, caveat, or question.
Tzeng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: